Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.6 CHF | -0.44% | +4.70% | +5.51% |
08:14am | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Sales 2024 * | 48.75B 44.53B | Sales 2025 * | 50.58B 46.2B | Capitalization | 201B 184B |
---|---|---|---|---|---|
Net income 2024 * | 10.23B 9.34B | Net income 2025 * | 11.78B 10.76B | EV / Sales 2024 * | 4.38 x |
Net Debt 2024 * | 12.24B 11.18B | Net Debt 2025 * | 11.23B 10.26B | EV / Sales 2025 * | 4.2 x |
P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
17.2
x | Employees | 76,057 |
Yield 2024 * |
3.66% | Yield 2025 * |
3.8% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | -0.44% | ||
1 week | +4.70% | ||
Current month | +2.50% | ||
1 month | +3.95% | ||
3 months | -3.15% | ||
6 months | +5.24% | ||
Current year | +5.51% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 18 M€ | +3.79% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 89.55 | -0.50% | 2 008 845 |
24-04-25 | 90 | +0.99% | 4,571,037 |
24-04-24 | 89.12 | +0.20% | 3,572,943 |
24-04-23 | 88.94 | +1.81% | 8,288,764 |
24-04-22 | 87.36 | +2.14% | 4,375,338 |
Delayed Quote Swiss Exchange, April 26, 2024 at 10:47 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.51% | 201B | |
+25.76% | 653B | |
+26.47% | 556B | |
-6.65% | 354B | |
+20.09% | 331B | |
+4.22% | 296B | |
+12.87% | 233B | |
-9.53% | 193B | |
-6.31% | 144B | |
-12.02% | 143B |
- Stock Market
- Equities
- NOVN Stock